who owns the patent for semaglutide Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. π Demand GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Novo Nordisk takes legal action
Pay in 4 interest-free payments of $5.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 24 - Aug 29





















![[PREORDER] Funko Pop!](https://cdn.shopify.com/s/files/1/0907/4137/5353/files/49448.jpg?v=1742373449)



